Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose ketamine plus sufentanil for postoperative analgesia after laparoscopic colorectal cancer surgery
ChiCTR2000040965Phase 4Recruiting
- Sponsor
- The First Hospital of Zibo
- Start
- Jan 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in colorectal cancer (CRC) and postoperative pain comparing Sufentanil alone with Low-dose ketamine plus sufentanil (2 arms). Primary endpoint: Postoperative pain score. Started Jan 2021; status: recruiting.
02
Drugs
ketaminesufentanil
03
Conditions
colorectal cancer (CRC)postoperative pain
Beyond the preview
Go deeper on ChiCTR2000040965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000040965.